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Background
• Therapeutic Plasma Exchange (TPE) is a 
procedure which removes and replaces blood 
plasma
• Plasma constitutes approximately 55% of blood 
volume and contains lipid transporters, globulins, 
fibrinogen, and hormones
• TPE is a common therapy used to treat many 
autoimmune and neurological diseases by 
removing autoantibodies from the blood
• Heparin and Acid-Citrate-Dextrose (ACD) are the 
most widely used anticoagulants in TPE
Experimental Timeline
Research Design and Methods
• TPE procedures will be performed in a non-
survivable pig model
• Stable-isotope 13C-linoleic acid tracers will be 
introduced into pigs 24 hours prior to the 
procedure
• Linoleic acid is one of two essential fatty acids 
which humans require through diet
• Pre- and Post- visceral and subcutaneous fat 
samples will be taken as a measure of baseline 
for isotope absorption and of isotope release
• Plasma aliquots will be collected incrementally for 
determination of total stable isotope turnover rate
ACD vs Heparin Anticoagulation
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• Heparin is known to activate lipoprotein lipases which 
hydrolyzes triglycerides into non-esterified fatty acids 
(NEFA)
• An enhanced release of NEFA’s into the blood due to 
heparin could result in excess loss of lipids and 
essential fatty acids during TPE
Figure 1. Experimental Flow Chart
Purpose
• This study explores the extent to which heparin, 
when compared to ACD, causes increased lipid 
loss during TPE that can result in wasting and 
essential fatty acid deficiencies
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• Anticoagulation techniques are necessary during TPE to 
maintain the fluidity of blood through the extracorporeal 
circuit
• ACD anticoagulation is preferred over heparin due to its 
low cost, safety, and rapid systemic clearing
• ACD has the potential to cause life-threatening 
hypocalcemia (low blood calcium levels)
• Patients in which ACD is not well tolerated are required to 
use heparin anticoagulation
Heparin as a Fatty Acid Mobilizer
Conclusion
Patients requiring TPE often need multiple 
sessions per week to treat their conditions. 
Repetitive TPE can place undue stress on 
the body of patients weakened by cancer or 
old age; especially when they are unable to 
compensate for nutrient loss. By studying 
the effects of different anticoagulation 
methods, we can gain a better insight into 
how to adjust patient care during a series of 
TPE procedures.
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